CLINICAL_TRIALS
trial_result
· 2023-05-06
Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum [Phase 2]
Summary
A Phase 2 trial evaluating SB206 for Molluscum Contagiosum has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novan, Inc. | Conditions: Molluscum Contagiosum | Phase 2 | Status: COMPLETED | Results posted: 2023-05-06